ArticlePharmacoEconomics2022

Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine.

Zoë Pieters et al.PubMed ↗Publisher ↗

No numbers read from the abstract.